In addition to providing Premier opportunity to conduct clinical trials at AIIMS Hospital, New Delhi, BBMCT also offers localization, interpretation, and transcription from and into Hindi for a wide range of technical, medical, and scientific fields. A total of 1,500 international businesses are using BBMCT’s services. Many of the world’s biggest technological, engineering, biomedical, and pharmaceutical companies trust us because of our specialisation, focus, industry-leading quality management standards, and customer-centered approach.
All main European, Asian, Middle Eastern, African, and American languages are covered by BBMCT’s translation services for the medical, scientific, and technical fields. It’s clear that BBMCT can thrive in many different settings. If you need help with global communications, BBMCT is the company for you.
To be specific, BBMCT is a translation agency that focuses on the medical, life sciences, and clinical research fields.
Languages spoken in Western and Eastern Europe, Asia, South America, and the Middle East are just some of the regions where we offer translation services for clinical research documentation. Clinical Research Organizations, Pharmaceutical Companies, and Makers of Medical Equipment and Supplies Comprise Our Client Base.
Many steps in bringing a medicine to market necessitate translation, including filings to regulatory agencies, production, marketing, and packaging. A considerable part of clinical research is done in multi-country trials and most pharmaceuticals that are marketed are created or manufactured abroad.
Because of the rising need for translated clinical research materials, especially those aimed at improving minority participation in clinical trials, cross-cultural adaptation is increasingly important in the field of medical translation.
BBMCT’s Real-World Evidence (RWE) experts help companies explore the impact of a therapy and/or disease in a real-world setting and generate real-world data that can support your proposition to regulators, payers, physicians and patients. We understand the need for interconnected, patient-specific that’s longitudinal in order to track outcomes over time, and we are helping many companies solve this challenge including with the use of hybrid prospective/retrospective RWE studies.